• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Inflamm Res . Influenza A (H1N1) and COVID-19 Pneumonias: An Evaluation in the Light of New Hematologic Indices

tetano

Editor, Senior Moderator
J Inflamm Res


. 2025 Sep 19:18:13103-13116.
doi: 10.2147/JIR.S545387. eCollection 2025. Influenza A (H1N1) and COVID-19 Pneumonias: An Evaluation in the Light of New Hematologic Indices

Mihrican Yeşildağ[SUP] 1 [/SUP], Rahim Kocabas[SUP] 2 [/SUP]



Affiliations
Abstract

Objective: Influenza A (H1N1) and COVID-19 viruses are two very different airway viral pneumonia agents that cause similar clinical manifestations and coinfections. The aim of this study was to investigate new laboratory indices, clinical and radiological findings that may help in the differential diagnosis of these two viral pneumonias.
Material and methods: Eighty-nine hospitalized patients, 38 with Influenza A (H1N1) and 51 with COVID-19 pneumonia, were retrospectively analyzed. Laboratory parameters, clinical, and radiological findings of the patients were obtained from their medical files. Numerous hematological and biochemical parameters (neutrophil, monocytes, mean corpuscular volume (MCV), albumin, uric acid, etc) were investigated and new indices (neutrophil/albumin ratio (NAR), lymphocyte-monocyte ratio (LMR), etc) were calculated. Both viral pneumonias were compared in terms of new hematological and biochemical indices and clinical and radiological outcomes.
Results: In terms of clinical symptoms, fever, cough, and shortness of breath were higher in influenza A (H1N1) pneumonia, while sore throat, headache, and malaise were higher in COVID-19 pneumonia. Consolidations in influenza A (H1N1) pneumonia and round ground-glass opacities in COVID-19 pneumonia were found as typical radiologic findings. The laboratory parameters most associated with COVID-19 pneumonia were monocytes (OR 27.327, %95 CI: 4.143-180.234, p=0.001), MCV (OR 1.130, %95 CI:1.011-1.262, p=0.031), albumin (OR 0.314, %95 CI:0.111-0.888, p=0.029) and uric acid (OR 1.631, %95 CI:1.055-2.522, p=0.028), and laboratory indices were LMR (OR 0.677, %95 CI:0.492-0.933, p=0.017) and NAR (OR 1.514, %95 CI:1.004-2.282, p=0.048).
Conclusion: The most significant laboratory parameters predictive of COVID-19 pneumonia were monocytes, uric acid, albumin, and MCV and the most effective indices were LMR and NAR. Round ground glass opacities were the primary radiological findings suggestive of COVID-19 pneumonia.

Keywords: COVID-19 pneumonia; hematologic indices; influenza A (H1N1); lymphocyte–monocyte ratio; neutrophil–albumin ratio.

 
Back
Top